In other tumor cells as reported in lymphoma, methylation of the promoter region can be one of the mechanisms that silence the expression of ASS1, and demethylating agents such as 5-aza-2′-deoxycytidine can induce the re-expression of ASS1 and confer resistance to ADI-PEG20 [66]. Here, ASS1 is linked to neoplasm.